Yoga should be encouraged in madrassas, but oppose Surya Namaskar, says UP Muslim cleric: 'Islam forbids…'
"I have supported yoga but opposed Surya Namaskar. Muslims cannot perform Surya Namaskar. Surya Namaskar is an act within yoga. Every man and woman should do yoga. Yoga should be done in madrasas and mosques too. But Surya Namaskar is bowing to the sun, worshipping the sun. Islam forbids all these things," said Razvi, president of the All India Muslim Jamaat.
According to a PTI report, Razvi took part in the celebrations of the International Day of Yoga at the Grand Mufti House near Dargah-e-Ala Hazrat in Bareilly. "Worshipping the sun is illegitimate in Islam. That is why we have forbidden everyone from doing Surya Namaskar. Surya Namaskar is not a part of Islam. Therefore, no Muslim should perform Surya Namaskar.'
"Yoga is also practised in Islam. Yoga is not part of a religion," he added.
The report further quoted the cleric as saying, "Surya Namaskar is a form of Sanatan Dharma, meaning Hindu worship, which Islam absolutely does not permit. Surya Namaskar is 'haram' in Islam."
Meanwhile, Uttar Pradesh minister JPS Rathore remarked: "Just as our sun is the truth, so is Surya Namaskar. So long as the sun rises, Surya Namaskar will also continue."
Rathore commented after performing yoga at Bareilly College ground on Saturday, the report added.
"Those who spit at the sun end up with the spit falling back on their faces. The same fate awaits those who oppose Surya Namaskar," the minister also said. "It's an ancient yoga practice that everyone should accept. There's nothing more narrow-minded than opposing it."
Razvi also recommended yoga for women. "Yoga is very important for women, as women move around much less compared to men; women mostly stay at home. Therefore, people who do more sedentary work are more susceptible to diseases."
"Yoga is an activity that makes small illnesses disappear on their own, and the body remains agile. So, my request to women is to do yoga for at least 20 minutes every day," he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
9 hours ago
- News18
Ayush ministry reaffirms commitment to promote evidence-based practices
New Delhi, Jul 24 (PTI)The National Expert Committee constituted by the Ayush ministry undertook a rigorous review of scientific, pharmacological and traditional data to refine safety documentation for four selected herbs. This initiative is aligned with the ministry's larger mandate to ensure that Ayush interventions meet global safety and quality standards, thereby enhancing public confidence and international recognition of Indian traditional medicines, the ministry said in a statement. The exercise involved a critical synthesis of Ayurvedic classical references, preclinical data, toxicology findings and available clinical literature, it said in the statement. As part of its ongoing efforts to strengthen the scientific evidence base of traditional medicine, the Ayush ministry has made significant progress in the development of safety dossiers for four important Ayush herbs — Gokshura (Tribulus terrestris), Tulsi (Ocimum sanctum), Haridra (Curcuma longa) and Chandrashura (Lepidium sativum). The National Expert Committee meeting was held from July 21 to 22 at the All India Institute of Ayurveda (AIIA), Goa. The committee, constituted by the Ministry of Ayush, co-chaired by Dr A Raghu, Deputy Director General (Ayush), and Dr J B Gupta, comprises senior experts and scientists from leading institutions including AIIA (Goa and New Delhi), AIIMS New Delhi, CCRAS, DIPSAR, ITRA, IIT Jodhpur, CIMAP and Savitribai Phule Pune University. 'The National Expert Committee undertook a rigorous review of scientific, pharmacological, and traditional data to refine safety documentation for the selected herbs," the statement said. The ministry commended the expert committee and collaborating institutions for their contributions and reaffirms its commitment to promoting evidence-based, safe and effective Ayush practices. PTI PLB KSS KSS (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: July 24, 2025, 22:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
10 hours ago
- News18
ICMR study finds shortfall in radiotherapy utilisation across all cancer types
Agency: Last Updated: July 24, 2025, 21:30 IST Representational image (Image: News18) New Delhi, Jul 24 (PTI) A recent ICMR study has highlighted a substantial shortfall in radiotherapy utilisation across all cancer types and underscored the need for interventions to meet the gap in machines required for equitable cancer care. Published in the BMC Cancer journal, the study stated that 28.5 per cent of cancer patients receive radiotherapy, which is lower than the estimated optimal rate of 58.4 per cent. Breast, head and neck, lung and cervical cancer account for 60 per cent of India's radiotherapy needs, it said. Data from the Australian Collaboration for Cancer Outcomes Research and Evaluation (CCORE) were used by the researchers of ICMR-National Centre for Disease Informatics and Research, Bengaluru, for conducting the study. Epidemiological data on stage, subsite and histology from the National Cancer Registry Programme were used to assess the optimal utilisation proportion for India. A sensitivity analysis was carried out. Similarly, the optimal radiotherapy fraction has also been calculated. These measures have been used to estimate the existing radiotherapy utilisation gap by comparing with the current radiotherapy utilisation from the cancer registry as well as to estimate the optimal radiotherapy machines required for the country. 'This study provides a comprehensive assessment of radiotherapy demand and existing gaps in radiotherapy utilisation and in the number of machines in India based on an epidemiological analysis of the cancer burden from the National Cancer Registry Programme. Our analysis shows that approximately 58 per cent of all cancer cases in India should ideally receive radiotherapy based on clinical indications. 'However, the current radiotherapy utilisation in India is only 28.5 per cent, which is less than half of the required level," the researchers said. The study also recommended that India would require 1,585 to 2,545 machines, which may increase to a range of 2,016 to 2,291 external beam radiotherapy machines if the assumptions from previous benchmark studies are followed. The burden of four cancer sites — breast, head and neck, lung and cervical cancer — constitutes around 60 per cent of the total radiotherapy requirement for cancer care in India, the study said. This points towards an increasing demand for radiotherapy in the coming years as there is expected to be a 70-100 per cent increase in breast, head and neck and lung cancer in low and middle income countries (LMIC). Radiotherapy utilisation of most cancer sites is lower compared to optimal radiotherapy utilisation. Among the major indicated cancer sites, the deficit is more prominent in lymphoma and lung cancer (relative deficit of more than 70 per cent), followed by prostate, breast and oesophagus, it said. The study mentioned that India accounts for 7 per cent of global cancer incidence, ranking third after China and the USA. By the end of 2025, the incidence of cancer in India is projected to reach 1.57 million cases, posing a significant public health challenge. As the fifth leading cause of death in the country, cancer demands urgent attention to improve prevention, diagnosis and treatment, it said. Radiotherapy, a cornerstone of cancer treatment, plays a crucial role in controlling tumour growth, reducing tumour size pre-surgery, and alleviating pain in advanced stages. However, its availability in low and middle-income countries like India remains insufficient due to high setup and operational costs, creating a significant gap between demand and resources. The World Health Organization (WHO) recommends a minimum of one radiotherapy machine (external radiotherapy machine) per million population, with an optimal target of four per million, the study stated. For India's projected population of 1.45 billion in 2025, this translates to a need for a minimum of 1,450 machines. Yet, only 794 megavoltage (MV) machines are currently available. The shortfall is about 45 per cent from the minimal required standard, the study said. The study highlighted that in India, greater investment is needed to expand radiotherapy facilities to meet the growing demands of cancer patients. 'Aside from increasing the number of equipment, addressing the inequitable distribution of radiotherapy services is also crucial. To align with the country's cancer burden and ongoing cancer control efforts, India must meet evidence-based targets for radiotherapy machine availability. 'As a part of this, India is also ramping up efforts to develop and deploy affordable indigenous radiotherapy machines to improve access and reduce dependence on costly imports," the study stated. Furthermore, a detailed situational study of radiation equipment deployment with its features and complexity, utilisation and throughput is required for informed planning and policymaking. Cancer screening and early detection programmes can facilitate the diagnosis of cancers at earlier stages. This could reduce the required quantum of radiotherapy shortly and thus, improve the overall survival of patients, the study said. The cancer registry data informs the policy-makers to identify gaps in radiotherapy access, assess resource needs and guide decisions to ensure equitable and effective cancer care delivery. Swipe Left For Next Video View all Optimal radiotherapy utilisation (RTU) calculated for India was higher than optimal radiotherapy utilisation estimation done for developed countries like 48·3 per cent for Australia and 51 per cent for European countries, the study said. The optimal RTU calculation for middle income countries also has an average optimal radiotherapy utilisation value of 52 per cent ranging from 47 to 56 per cent. PTI PLB KSS KSS (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments News agency-feeds ICMR study finds shortfall in radiotherapy utilisation across all cancer types Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
News18
11 hours ago
- News18
ADIA seeks CCI nod to acquire minority stake in Micro Life Sciences
New Delhi, Jul 24 (PTI) Abu Dhabi's sovereign wealth fund ADIA has sought approval from the Competition Commission of India (CCI) to acquire a 3 per cent stake in medical devices firm Micro Life Sciences Pvt Ltd (Meril) in a USD 200 million deal. The development came after a wholly-owned subsidiary of Abu Dhabi Investment Authority (ADIA) on Monday said it has entered into definitive agreements to invest USD 200 million for a 3 per cent stake in Meril. ADIA, through its affiliate Platinum Jasmine A 2018 Trust (acting through its trustee Platinum Owl C 2018 RSC Ltd), is acquiring a stake in Gujarat-based Meril. 'The acquirer (Platinum Jasmine A 2018 Trust) proposes to subscribe to certain equity shares proposed to be issued by the target (Micro Life Sciences) and acquire certain equity shares of the target from Bilakhia Holdings Pvt Ltd, amounting to approximately 3.06 per cent shareholding in the target," according to a notice filed with the CCI on Wednesday. Platinum Jasmine A 2018, Trust and Micro Life Sciences said the proposed transaction does not have any impact on any relevant market in India, let alone any appreciable adverse effect on competition, and therefore, the definition of the relevant product and geographic market may ultimately be left open. Following the transaction, ADIA said this investment values the firm (MERIL) at an enterprise value of USD 6.6 billion. Founded by the Bilakhia Group, Meril is a global innovator in medical technology with a focus on clinically advanced solutions across multiple specialities, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics and surgical robotics. Headquartered in Vapi, Gujarat, Meril employs more than 13,000 people, has over 35 global subsidiaries, and serves healthcare systems in around 150 countries. 'This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our…clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions," Sanjeev Bhatt, Senior Vice President – Strategy at Meril, said. Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Abu Dhabi government through a strategy focused on long-term value creation. PTI HG HG BAL BAL view comments First Published: July 24, 2025, 21:00 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
